IDiyas

For the Inventor, By the Inventor

Chita-gun, Japan

Nakao Kojima

USPTO Granted Patents = 13

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 44(Granted Patents)


Location History:

  • Taketoyo-cho, JP (1999 - 2001)
  • Aichi-ken, JP (2000 - 2001)
  • Nagoya, JP (1996 - 2002)
  • Chita-gun, JP (2002)

Company Filing History:

goldMedal13 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1996-2002

Loading Chart...
13 patents (USPTO):Explore Patents
1. 6416979 - 5-substituted picolinic acid compounds production by Marasmiellus sp (2002-07-09),
2. 6391616 - Oidiodendron strain for the production of terpenoid lactone compounds (2002-05-21),
3. 6225339 - Terpenoid lactone compounds and their production process (2001-05-01),
4. 6221899 - Terpenoid lactone compounds and their production process (2001-04-24),
5. 6194442 - 5-substituted picolinic acid compounds and their method of use (2001-02-27),
6. 6187568 - Macrocyclic lactone compounds and their production process (2001-02-13),
7. 6034107 - 5-Substituted picolinic acid compounds and their production process (2000-03-07),
8. 6001998 - Macrocyclic lactone compounds and their production process (1999-12-14),
9. 5942619 - Quinolone compounds for the treatment of disorders caused by (1999-08-24),
10. 5885959 - Cyclic peptide compounds and their production process (1999-03-23),
11. 5801023 - Antiparasitic pyrrolobenzoxazine compounds (1998-09-01),
12. 5674732 - Rapamycin producer (1997-10-07),
13. 5494820 - Streptomyces braegensis strain and its cultivation in a process for (1996-02-27),

Title: The Innovative Contributions of Nakao Kojima

Introduction

Nakao Kojima is a prominent inventor based in Chita-gun, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 13 patents to his name, Kojima's work has had a substantial impact on medical research and drug development.

Latest Patents

One of Kojima's latest patents involves the production of 5-substituted picolinic acid compounds by utilizing a Marasmiellus sp - Oidiodendron strain. This invention focuses on the production of terpenoid lactone compounds. The process includes cultivating the strain FERM BP-5778 and isolating the terpenoid lactone compounds from the fermentation broth. Additionally, the invention provides a pharmaceutical composition that includes the terpenoid lactone compound, which is beneficial in treating IL-1 and TNF mediated diseases.

Career Highlights

Kojima is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to explore innovative solutions in drug development and contribute to advancements in healthcare.

Collaborations

Throughout his career, Kojima has collaborated with notable colleagues, including Hiroyuki Nishida and Nobuji Yoshikawa. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Nakao Kojima's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…